.

Deeper Knowledge, Faster

  • Predict branded drug patent expiration
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Novartis
Mallinckrodt
Dow
US Department of Justice
Baxter
Merck
McKesson
Johnson and Johnson
Cerilliant
Colorcon

Generated: July 21, 2017

DrugPatentWatch Database Preview

Details for Patent: 8,431,615

« Back to Dashboard

Which drugs does patent 8,431,615 protect, and when does it expire?


Patent 8,431,615 protects INCIVEK and is included in one NDA.

This patent has twenty patent family members in thirteen countries.

This patent has expired prematurely due to non-payment of maintenance fees. See details below.

Summary for Patent: 8,431,615

Title:Dose forms
Abstract: The present invention relates to antiviral therapies and compositions for treating or preventing Hepatitis C infections in patients and relates to other methods disclosed herein. The invention also relates to kits and pharmaceutical packs comprising compositions and dosage forms. The invention also relates to processes for preparing these compositions, dosages, kits, and packs.
Inventor(s): Chu; Hui-May (Natick, MA), Ette; Ene (Framingham, MA), McNair; Lindsay (Allston, MA), Alam; John (Cambridge, MA)
Assignee: Vertex Pharmaceuticals Incorporated (Cambridge, MA)
Application Number:11/264,746
Patent Claim Types:
see list of patent claims
Compound;

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use
Vertex Pharms
INCIVEK
telaprevir
TABLET;ORAL201917-001May 23, 2011DISCNNoNo8,431,615► Subscribe METHOD OF TREATING CHRONIC HEPATITIS C
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Patent: 8,431,615

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Russian Federation2393863► Subscribe
Russian Federation2007119725► Subscribe
Norway20072733► Subscribe
Malaysia141025► Subscribe
Mexico2007005179► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Farmers Insurance
Queensland Health
McKesson
Cerilliant
Baxter
McKinsey
Covington
Federal Trade Commission
AstraZeneca
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot